GlassScriptPhysician profile
Stephanie Dawn Stevens
NPI 1487179362
$989.75
in general payments reported to CMS, 2019-2025
10 companies · $436 in 2025
The $436 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $75.71 · 2024: $478 · 2025: $436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $891 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $890.75 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pulmonx Corporation | $375.97 | 2023-2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter |
| Daiichi Sankyo INC. | $152.56 | 2023-2025 | Enhertu, Datroway |
| Astrazeneca Pharmaceuticals LP | $134.38 | 2024-2025 | Imfinzi |
| Gilead Sciences, INC. | $99.00 | 2024 | Trodelvy |
| Merck Sharp & Dohme LLC | $84.37 | 2024-2025 | Keytruda |
| Lilly USA, LLC | $48.22 | 2023-2024 | Retevmo |
| Emd Serono, INC. | $27.06 | 2024 | |
| Array Biopharma INC | $26.73 | 2025 | Mektovi, Xalkori, Lorbrena |
| Exelixis INC. | $22.62 | 2025 | Cabometyx |
| Octapharma USA, INC. | $18.84 | 2025 | Fibryga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Stevens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.